Genetic Testing in Persons with Age-Related Macular Degeneration and the Use of the AREDS Supplements: To Test or Not to Test?. Ophthalmology, 122, 212-215. presented at the 01/2015. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/25456150. (2015).
No Clinically Significant Association Between CFH and ARMS2 Genotypes and Response to Nutritional Supplements: AREDS Report Number 38. Ophthalmology, 121, 2173-2180. presented at the 11/2014. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/24974817. (2014).
Risk Assessment Model for Development of Advanced Age-Related Macular Degeneration. Arch Ophthalmol, 129, 1543-1550. presented at the 12/2011. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/21825180. (2011).
Retinal Risk Factors and Progression to Geographic Atrophy in Age-Related Macular Degeneration. In Annual Meeting, Association for Research in Vision and Ophthalmology (ARVO). presented at the 21/05/2005, Fort Lauderdale, FL. Retrieved from http://www.arvo.org/Conferences_and_Courses/Past_Conferences/. (2005).
Associations between c-reactive protein and age-related macular degeneration. presented at the 2004.. (2004).
Cognitive function in the Age-Related Eye Disease Study (AREDS). presented at the 2004.. (2004).